Understanding Risk Factors and Determinants for Neuropathic Pain
NCT02402361 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-05-20
Summary
Understanding risk factors and determinants for neuropathic pain.
Conditions
- Diabetic Neuropathy
Sponsors & Collaborators
- collaborator OTHER
-
Rambam Health Care Campus
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-04-01
- Primary Completion
- 2020-07-30
- Completion
- 2021-03-01
Countries
- Israel
Study Locations
More Related Trials
-
A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)
NCT00837941 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain
NCT02666456 ·Status: UNKNOWN
-
Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain
NCT04431778 ·Status: UNKNOWN ·Phase: PHASE2
-
Chronic Neuropathy Following Chemotherapy
NCT02654691 ·Status: COMPLETED
-
Pretreatment Identification of Duloxetine Success in Neuropathic Pain Patients
NCT01363284 ·Status: COMPLETED ·Phase: NA
-
Analysis of Cortical Excitability in Neuropathic Pain
NCT00789347 ·Status: UNKNOWN
-
Treatment for Painful Diabetic Neuropathy
NCT05937984 ·Status: UNKNOWN ·Phase: NA
-
Phase II Dose Titration Study in Patients With Neuropathic Pain
NCT00736151 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating a Model for Acute Ischemic Pain in Humans
NCT02192242 ·Status: COMPLETED ·Phase: NA
-
Peripheral Physiological Measures as Determinants of Pain Risk
NCT02985294 ·Status: UNKNOWN
-
Neuropathic Pain Database
NCT00669006 ·Status: COMPLETED
-
Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury
NCT05805683 ·Status: RECRUITING ·Phase: NA
-
A Study to Evaluate the Safety and Effectiveness of Mirogabalin in Chinese Adult Patients With Diabetic Peripheral Neuropathic Pain (DPNP) in Real-world Clinical Practice Setting (ReMIssion Study)
NCT06812117 ·Status: ACTIVE_NOT_RECRUITING
-
Ketamine and Neuropathic Pain
NCT02467517 ·Status: UNKNOWN ·Phase: PHASE2
-
A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)
NCT06203002 ·Status: COMPLETED ·Phase: PHASE2
-
Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients (OCAPA)
NCT04673981 ·Status: RECRUITING ·Phase: NA
-
Probing the Role of Sodium Channels in Painful Neuropathies
NCT02243475 ·Status: UNKNOWN
-
Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
NCT00603265 ·Status: COMPLETED ·Phase: PHASE2
-
Economic Medical Evaluation of Treatment of the Neuropathic Pain Rebel by Cortical Stimulation
NCT00241566 ·Status: COMPLETED ·Phase: PHASE4
-
Neuropathic Pain in Patients With Cancer
NCT00474916 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain
NCT04455633 ·Status: COMPLETED ·Phase: PHASE2
-
DOLORisk: Research on Risk Factors and Determinants for Neuropathic Pain
NCT04888455 ·Status: COMPLETED
-
Efficacy Study of Nabilone in the Treatment of Diabetic Peripheral Neuropathic Pain
NCT01035281 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study for the Treatment of Diabetic Peripheral Neuropathic Pain
NCT00552175 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of the N0750 Compared to Monotherapies in the Treatment of Painful Diabetic Peripheral Neuropathy
NCT06715462 ·Status: WITHDRAWN ·Phase: PHASE3